Literature DB >> 15110445

Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer--a systematic review.

George Rodrigues1, Michael Lock, David D'Souza, Edward Yu, Jake Van Dyk.   

Abstract

BACKGROUND AND
PURPOSE: To perform a systematic review of the predictive ability of various dose-volume histogram (DVH) parameters (V(dose), mean lung dose (MLD), and normal tissue complication probability (NTCP)) in the incidence of radiation pneumonitis (RP) caused by external-beam radiation therapy. METHODS AND MATERIALS: Studies assessing the relationship between CT-based DVH reduction parameters and RP rate in radically treated lung cancer were eligible for the review. Synonyms for RP, lung cancer, DVH and its associated parameters (NTCP, V(20), V(30), MLD) were combined in a search strategy involving electronic databases, secondary reference searching, and consultation with experts. Individual or group data were abstracted from the various reports to calculate operating characteristics and odds ratios for the different DVH metrics.
RESULTS: A total of 12 published studies and two abstracts were identified. Eleven studies assessed V(dose), seven assessed MLD, and eight assessed NTCP. Nine studies exclusively analyzed the association between various DVH metrics and RP risk. Five studies also analyzed other patient, tumor, and treatment variables in conjunction with standard DVH metrics. A direct comparison between studies and the generation of summary statistics (i.e. meta-analysis) could not be achieved due to significant predictive and outcome variable heterogeneity. Most studies did show an association between DVH parameters and RP risk. However, overall accuracy, sensitivity, specificity, and positive predictive value were generally poor to fair for all three classes of DVH metrics.
CONCLUSIONS: An association between DVH parameters and RP risk has been demonstrated in the literature. However, the ideal DVH metric with excellent operating characteristics, either alone or in a model with other predictive variables, for RP risk prediction has not yet been identified. Several recommendations for reporting and conduct of future research into the association between DVH metrics and RP risk are provided.

Entities:  

Mesh:

Year:  2004        PMID: 15110445     DOI: 10.1016/j.radonc.2004.02.015

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  124 in total

1.  Spanish radiobiological pattern of care in lung cancer: a GOECP/SEOR study.

Authors:  J A González; M Chust; R Delgado; A Gómez; N Rodríguez; M J Ruiz; F Casas
Journal:  Clin Transl Oncol       Date:  2010-04       Impact factor: 3.405

2.  Simvastatin attenuates radiation-induced murine lung injury and dysregulated lung gene expression.

Authors:  Biji Mathew; Yong Huang; Jeffrey R Jacobson; Evegeny Berdyshev; Lynnette M Gerhold; Ting Wang; Liliana Moreno-Vinasco; Gabriel Lang; Yutong Zhao; Chin Tu Chen; Patrick J LaRiviere; Helena Mauceri; Saad Sammani; Aliya N Husain; Steven M Dudek; Viswanathan Natarajan; Yves A Lussier; Ralph R Weichselbaum; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2010-05-27       Impact factor: 6.914

3.  Radiation-induced changes in breathing frequency and lung histology of C57BL/6J mice are time- and dose-dependent.

Authors:  T Eldh; F Heinzelmann; A Velalakan; W Budach; C Belka; V Jendrossek
Journal:  Strahlenther Onkol       Date:  2012-03       Impact factor: 3.621

4.  Dose-mass inverse optimization for minimally moving thoracic lesions.

Authors:  I B Mihaylov; E G Moros
Journal:  Phys Med Biol       Date:  2015-04-24       Impact factor: 3.609

5.  A novel phantom for characterization of dual energy imaging using an on-board imaging system.

Authors:  Maksat Haytmyradov; Rakesh Patel; Hassan Mostafavi; Murat Surucu; Adam Wang; Matthew M Harkenrider; John C Roeske
Journal:  Phys Med Biol       Date:  2019-01-21       Impact factor: 3.609

6.  Advantages of CyberKnife for inoperable stage I peripheral non-small-cell lung cancer compared to three-dimensional conformal radiotherapy.

Authors:  An-Na Tong; Peng Yan; Guang-Hui Yuan; Xiao-Yan Lv; Hai Gong; Hui Zhao; Yan-Ming Wang
Journal:  Mol Clin Oncol       Date:  2014-12-10

7.  Unraveling biophysical interactions of radiation pneumonitis in non-small-cell lung cancer via Bayesian network analysis.

Authors:  Yi Luo; Issam El Naqa; Daniel L McShan; Dipankar Ray; Ines Lohse; Martha M Matuszak; Dawn Owen; Shruti Jolly; Theodore S Lawrence; Feng-Ming Spring Kong; Randall K Ten Haken
Journal:  Radiother Oncol       Date:  2017-02-22       Impact factor: 6.280

8.  Analysis of risk factors for pulmonary complications in patients with limited-stage small cell lung cancer : A single-centre retrospective study.

Authors:  Beata Sas-Korczyńska; Elżbieta Łuczyńska; Wojciech Kamzol; Andrzej Sokołowski
Journal:  Strahlenther Onkol       Date:  2016-10-26       Impact factor: 3.621

9.  The Influence of Radiotherapy on AIM2 Inflammasome in Radiation Pneumonitis.

Authors:  Qianyu Zhang; Qinyong Hu; Yuxin Chu; Bin Xu; Qibin Song
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

10.  Feasibility of image registration and intensity-modulated radiotherapy planning with hyperpolarized helium-3 magnetic resonance imaging for non-small-cell lung cancer.

Authors:  Rob H Ireland; Chris M Bragg; Mark McJury; Neil Woodhouse; Stan Fichele; Edwin J R van Beek; Jim M Wild; Matthew Q Hatton
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.